Phase I-II study of high-dose etoposide in patients with refractory breast cancer.
Fraschini
G
G
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
Holmes
F A
FA
Esparza
L
L
Theriault
R L
RL
Buzdar
A U
AU
Hortobagyi
G N
GN
D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans
D005047:Etoposide